Immunopathogenic mechanisms of dry eye disease
干眼病的免疫致病机制
基本信息
- 批准号:8539627
- 负责人:
- 金额:$ 39.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2014-09-29
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAdultAffectAge related macular degenerationAgingAmericanAntigen-Presenting CellsBlindnessCCL2 geneCCL20 geneCCL3 geneCCL4 geneCCRCCR1 geneCCR5 geneCCR6 geneCD11c AntigensCD4 Positive T LymphocytesCD80 geneCXCL10 geneCXCL11 geneCXCL9 geneCXCR3 geneCell Culture TechniquesCellsClinicalConditioned Culture MediaConfocal MicroscopyCorneaCorneal UlcerCyclosporineDevelopmentDiseaseElementsEpithelialExpenditureEyeEye diseasesFigs - dietaryFlow CytometryFrequenciesFunctional disorderGenerationsGlossaryGrowthHigh PrevalenceHistocompatibility Antigens Class IIHome environmentHomingIL17 geneIL4 geneIL6 geneITGAM geneImmuneImmune System DiseasesImmunityIn Situ Nick-End LabelingIndividualInfectionInfiltrationInflammationInflammatoryInterferon Type IIInterferonsInterleukin-1Interleukin-10Interleukin-12Interleukin-17Interleukin-6InterleukinsKineticsKnowledgeLangerhans cellLeadLengthLigandsLymphangiogenesisLymphaticLymphoidLymphoid TissueMediatingMessenger RNAMolecularMorphologyNerveNerve DegenerationNerve FibersNeuritesNeuronsNeuropathyPathogenesisPerformance at workPeripheralPopulationPrevalenceProductivityProteinsPurinoceptorRANTESRegulatory T-LymphocyteResearchRiskSensorySeveritiesSignal TransductionStressSymptomsT cell responseT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsTNF geneTNFRSF5 geneTestingTh1 CellsTransgenic MiceTrigeminal SystemTumor Necrosis Factor-alphaVascular Endothelial Growth Factor CVascular Endothelial Growth Factor DVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth FactorsVisionVisualWorkbasebeta-Chemokinesblink reflexeschemokinechemokine receptorcorneal scarcytokineextracellulareye drynessin vivointerleukin-23lymph nodeslymphatic vesselmonocytemouse modelneuron apoptosisocular surfacepublic health relevancereceptor bindingreceptor expressionterthienyltherapeutic targettrafficking
项目摘要
DESCRIPTION (provided by applicant): Dry eye disease (DED), an immune disorder of largely unknown pathogenesis, is characterized by sustained ocular surface and in particular corneal inflammation, and disruption of the ocular surface epithelial barrier, which in severe cases can lead to blindness from corneal ulceration and scarring. DED has a very high prevalence, almost triple that of age-related macular degeneration, affecting many millions of individuals in the US alone, and its prevalence is set to double in the coming decades with the aging of the population. Current expenditures for treating DED surpass $1 billion dollars annually, and because it often affects visual function in working adults, it leads to lost productivity by impacting job performance. While immunity and inflammation have been implicated in its pathogenesis, very little is known about the precise immunopathogenic mechanisms of DED except that disease activity is sustained by ongoing activation and infiltration of the ocular surface by CD11b+ monocytes and CD4+ T cells. We have recently demonstrated that pathogenic T cells in DED are generated in the draining lymph nodes, but the cellular and molecular mechanisms that (i) mediate trafficking of immune cells from the eye to the lymphoid tissues to prime T cells, (ii) promote T cell stimulation and (iii) T cell homing onto the ocular surface remain unknown. In addition, (iv) while corneal nerve loss and dysfunction are important aspects of DED, very little is understood about the mechanisms that effect nerve degeneration in DED. The objectives of this project are to (i) precisely define the molecular and cellular pathogenic mechanisms of DED, and (ii) identify possible targets for treatment of DED. We hypothesize that pathogenesis of DED is associated with mobilization of mature corneal antigen-presenting cells (APC) to the lymphoid compartment where they can prime T cells, which can in turn home to the ocular surface to induce epithelial disease and neuropathy. We propose four specific aims to test this hypothesis in a validated and well-characterized mouse model of DED. The Specific Aims focus on identifying the mechanisms that (1) induce maturation of corneal APC, (2) facilitate APC trafficking to the lymphoid compartment, (3) lead to generation and peripheralization of different (Th1 and Th17) pathogenic CD4+ T cell subsets, and (4) cause corneal nerve degeneration. It is anticipated that the overall impact of this research will be significant given the high prevalence of DED and the general dearth of knowledge regarding its immunopathogenesis.
PUBLIC HEALTH RELEVANCE: Dry eye disease is an inflammatory disorder of the ocular surface, associated with visual dysfunction and heightened risk of corneal scarring and infection, with as of yet poorly understood immunopathogenesis. We propose here to determine the specific immune-based cellular and molecular pathogenic elements of dry eye disease. The hope is that precise understanding of distinct pathogenic mechanisms will yield important therapeutic targets which could be useful in the management of the millions of Americans suffering from severe dry eye, and tens of millions of others with less severe symptoms.
描述(申请人提供):干眼病(DED)是一种发病机制不明的免疫性疾病,其特征是持续的眼表,特别是角膜炎症,以及眼表上皮屏障的破坏,在严重的情况下,可导致因角膜溃疡和疤痕而致盲。DED的患病率非常高,几乎是老年性黄斑变性的三倍,仅在美国就有数百万人受到影响,随着人口老龄化,其患病率在未来几十年将翻一番。目前用于治疗DED的费用每年超过10亿美元,由于它经常影响在职成年人的视觉功能,因此它会影响工作绩效,从而导致生产力下降。虽然免疫和炎症与DED的发病机制有关,但对DED的确切免疫致病机制知之甚少,除了CD11b+单核细胞和CD4+T细胞持续激活和渗透到眼表维持疾病活动。我们最近已经证明DED的致病T细胞是在引流的淋巴结中产生的,但(I)介导免疫细胞从眼睛到淋巴组织到原始T细胞的运输,(Ii)促进T细胞刺激和(Iii)T细胞归巢到眼表的细胞和分子机制尚不清楚。此外,(Iv)虽然角膜神经丢失和功能障碍是DED的重要方面,但对DED中影响神经变性的机制了解很少。该项目的目标是(I)准确确定DED的分子和细胞致病机制,以及(Ii)确定治疗DED的可能靶点。我们假设DED的发病机制与成熟的角膜抗原提呈细胞(APC)动员到淋巴间隔室有关,在那里它们可以激活T细胞,而T细胞又可以回到眼表,导致上皮性疾病和神经病变。我们提出了四个特定的目标来验证这一假设,在一个经过验证的和特征良好的DED小鼠模型中。其具体目标集中于确定(1)诱导角膜APC成熟,(2)促进APC转运至淋巴室,(3)导致不同(Th1和Th17)致病的CD4+T细胞亚群的产生和周围化,以及(4)导致角膜神经退化的机制。考虑到DED的高患病率以及对其免疫发病机制的普遍缺乏,预计这项研究的总体影响将是显著的。
公共卫生相关性:干眼病是一种眼表面炎症性疾病,与视觉功能障碍和角膜瘢痕形成和感染的风险增加有关,目前尚不清楚其免疫发病机制。我们建议在此确定干眼病的特定免疫细胞和分子致病因素。人们希望,对不同致病机制的准确理解将产生重要的治疗目标,这些目标可能有助于管理数百万患有严重干眼的美国人,以及其他数千万症状不那么严重的人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Reza Dana其他文献
Reza Dana的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Reza Dana', 18)}}的其他基金
The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival
供体糖尿病对角膜免疫细胞和移植物存活的影响
- 批准号:
10707166 - 财政年份:2022
- 资助金额:
$ 39.81万 - 项目类别:
Therapeutic Function of alpha-Melanocyte Stimulating Hormone (α-MSH) in Acute Injury and Chronic Degeneration of Corneal Endothelium
α-黑色素细胞刺激激素(α-MSH)在角膜内皮急性损伤和慢性变性中的治疗作用
- 批准号:
10394920 - 财政年份:2021
- 资助金额:
$ 39.81万 - 项目类别:
Therapeutic Function of alpha-Melanocyte Stimulating Hormone (α-MSH) in Acute Injury and Chronic Degeneration of Corneal Endothelium
α-黑色素细胞刺激激素(α-MSH)在角膜内皮急性损伤和慢性变性中的治疗作用
- 批准号:
10191281 - 财政年份:2021
- 资助金额:
$ 39.81万 - 项目类别:
Efficacy of the Neuropeptide Alpha-Melanocyte Stimulating Hormone (α-MSH) in Promoting Survival of Corneal Endothelial Cells in Eye Banking and Transplantation
神经肽α-黑素细胞刺激激素(α-MSH)在眼库和移植中促进角膜内皮细胞存活的功效
- 批准号:
9762115 - 财政年份:2018
- 资助金额:
$ 39.81万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 39.81万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 39.81万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 39.81万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 39.81万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 39.81万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 39.81万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)